on KindlyMD, Inc
KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
KindlyMD, Inc. (NASDAQ:KDLY) released its financial results for Q2 2024, showcasing significant strides in insurance reimbursement and financial positioning. The company's insurance reimbursements increased by 163.7%, totaling $126,325 for H1 2024, compared to $0 in H1 2023.
CEO Tim Pickett highlighted the successful IPO, raising $6 million, aiding in expanding comprehensive insurance coverage to nearly 80% across Utah.
Despite a revenue decline of 34.8%, KindlyMD is focusing on growing its insurance billing segment. Operational expenses rose by 6.0%, with net losses standing at $0.26 per share for Q2 2024.
KindlyMD is committed to expanding its footprint through acquisitions, tapping into Utah's fragmented market to enhance efficiency and margins. With $4.74 million in cash reserves, the company is poised for continued growth and expansion.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all KindlyMD, Inc news